Registration from the meeting of the working group of MZ SR, responsible for the analysis of the reporting of the consumption of medicinal products in Slovakia in OECD statistics, on 14.02.2017 at 09.30 am. on MZ SR

For MZ SR:

Peter Mrva, Director of OHZT
Michaela Laktis, IZP
Erika Hanzely, Official of the OHZT

For NCZI:

Martina Nagy, Director of SZIAS
Martina Vrbiková, ORaZŠ
Zuzana Vallová, SPA

For SUKL:

Adam Greško
Kamil Fleak

For the AIFP:

Katarína Slezáková
Petra Szilágyi

The meeting was opened by the Director of the Health Assessment Department MVDr. Mgr. Peter Mrva, MPH.

Programme

1. NCZI representative informed present that no shift in the analysis of drug consumption is possible, while we do not have an actual valid database for the defined daily dose (DDD).

They are important for the NCZI to report structured data of the supplement of the product included in the list of categorised products of the SWD, Which he doesn't have right now.

2. AIFM ordered structured WHO DDD database. When data is delivered, data should be paired with the database medicine-source SUKL.

3. For SUKL is official data processor PCR processing data from large-scale distributors.

Tasks

1. The AIFM will deliver the NCZI database to DDD from WHO as soon as he receives it.

2. NCZI puts the foundation of the SUKL on the required scope of details on medicinal products - data structure with a concrete example. Delivered immediately after the meeting.

NCZI will check the date until To be transmitted to the OECD 2016 data on drug consumption at the latest. To 20.02.2017.

NCZI will check for budget eHealth can cover the financing of the costs that the SUKL will have.

3. SUKL ensures structure repair database so that it contains all the necessary details and they are entered at the marketing authorisation of medicinal products.

SUKL will check that the company is MCR able to use the current drug consumption database to report to the OECD by: replace the DDD from the WHO database. Date until 20.02.2017.

SUKL finds the costs, time needed where appropriate, the necessary scope of work to adapt the database of medicinal products to include all details of all authorised medicinal products in the structure required by NCZI.

4. Ministry addresses Statistical the office of the Slovak Republic, which collects data on health expenditure. The subject of discussion will be Indicator- total expenditure on medicines.

Based on the outcome of the hearing, Working Party on the Recommendation on whether to report on the consumption of medicines for 2016 Using consumption data, the source shall be MCR with the replacement of the SDL for DDD; or use consumption data - NCZI source using DDD.

Consumption for 2017 will report based on consumption data - NCZI source using DDD.